McKesson and HCA Healthcare are pleased to announce a joint venture combining US Oncology Research and Sarah Cannon Research Institute. Effective October 31, 2022, the new Sarah Cannon Research Institute joint venture is a fully integrated oncology research organization aimed at expanding clinical research, accelerating drug development and increasing availability and access to clinical trials for community oncology providers and patients, including those in underserved communities. Read more here. Additional changes to this page will be coming soon.
Benefits of Offering Clinical Trials for Oncology Practices
The US Oncology Network is a worldwide leader in cancer research, and many practices in The Network offer their patients a chance to participate in some of the most advanced cancer clinical trials available today. Clinical trials provide patients the opportunity for a better outcome and quality of life, while playing a vital role in the fight against cancer. These novel cancer clinical trials are usually only available in major academic medical centers or hospital systems located in large cities, but practices in The US Oncology Network make them accessible to patient’s right in their local communities where they have the support of family and friends.
Watch the video to hear how the ability to offer clinical trial enrollment has made a difference in patient care for practices in The Network.
Practices in The US Oncology Network have:
- Offered more than 2,000 cancer clinical trials to their patients
- Enrolled more than 88,000 patients in oncology clinical trials in communities across the country
- Contributed to 100 FDA-approved cancer therapies
At any one time, more than 500 oncology clinical trials are in progress across The Network for many cancer diagnoses. Visit our research site to see if there is a clinical trial available that might help you.
Find a Clinical Trial
